We are live on ! Find out more
ICCC icon

ImmuCell
ICCC

28 hedge funds and large institutions have $8.84M invested in ImmuCell in 2026 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

732% more capital inflows, than outflows

Capital inflows: $2.87M | Capital outflows: $345K

75% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 4

67% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 3

4% more funds holding

Funds holding: 27 → 28 (+1)

0.99% more ownership

Funds ownership: 14.44% → 15.43% (+0.99%)

Holders
28
Holders Change
+1
Holders Change %
+3.7%
% of All Funds
0.34%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
7
Reduced
4
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$621K
2
Bailard
Bailard
California
+$64.7K
3
Mesirow Financial Investment Management
Mesirow Financial Investment Management
Illinois
+$38.4K
4
HighTower Advisors
HighTower Advisors
Illinois
+$32K
5
Northern Trust
Northern Trust
Illinois
+$23.2K

Top Sellers

Rank Fund Capital Flow
1
DIG
Dauntless Investment Group
New Hampshire
-$244K
2
Geode Capital Management
Geode Capital Management
Massachusetts
-$41.5K
3
Citadel Advisors
Citadel Advisors
Florida
-$23.7K
4
Steadtrust
Steadtrust
Texas
-$15.4K
5
Bank of America
Bank of America
North Carolina
-$12.5K

ICCC Hedge Fund Activity: Q1 2026 in Review

28 of the 8,226 institutional investors tracked by Wall St. Rank reported a position in ImmuCell (ICCC) for Q1 2026, worth a combined $8.84M — up 9.9% from $8.04M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new ICCC positions and 3 closed out — a net gain of 2 holders — while 7 added to existing stakes and 4 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $621K. The largest seller was Dauntless Investment Group, exiting entirely with an estimated $244K sold.

  • 28 institutional investors held ImmuCell (ICCC) as of Q1 2026, up from 27 in Q4 2025.
  • Funds reported $8.84M of ImmuCell stock for Q1 2026, up 9.9% quarter-over-quarter.
  • 5 funds opened new ImmuCell positions in Q1 2026 and 3 closed out, a net change of +2 holders.
  • The largest ImmuCell buyer in Q1 2026 was Morgan Stanley, an estimated $621K added.
  • The largest ImmuCell seller in Q1 2026 was Dauntless Investment Group, an estimated $244K sold.

Based on aggregated 13F filings for Q1 2026.